side effects of tirzepatide and semaglutide caused roughly half as many patients to stop treatment because gastrointestinal as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Semaglutide and Tirzepatide Side Effects

F prausnitzii abundance doubled following the administration of a GLP-1 receptor agonist, leading researchers to believe that this may be one of the ways the medication works to improve glucose tolerance

If you experience heart palpitations while taking semaglutide, it is important to assess how often they occur, how long they last, and whether they come with other symptoms like dizziness, chest pain, or shortness of breath

Naturally, many people worry about regaining lost weight or experiencing unpleasant withdrawal symptomsbut is that inevitable

While rare, pancreatitis risk increases in patients with personal or family history of pancreatic disease

J Mol Neurosci 59(4):544553

Semaglutide reduced ELF score and VCTE-measured liver stiffness, and improved N-terminal type III collagen propeptide (PRO-C3) and the FibroScan-AST (FAST) score, markers associated with fibrotic activity and risk stratification in MASLD [7,13,14]